Jeffrey W Sherman's Net Worth
$66.5 Million
Who is Jeffrey W Sherman?
Jeffrey W Sherman has an estimated net worth of $66.5 Million. This is based on reported shares across multiple companies, which include Horizon Therapeutics Public Ltd Co, XERIS PHARMACEUTICALS INC, Xeris Biopharma Holdings, Inc., Strongbridge Biopharma plc, Larimar Therapeutics, Inc., IDM PHARMA, INC., and NEOPHARM INC.
SEC CIK
Jeffrey W Sherman's CIK is 0001230482
Past Insider Trading and Trends
2021 was Jeffrey W Sherman's most active year for acquiring shares with 26 total transactions. Jeffrey W Sherman's most active month to acquire stocks was the month of December. 2023 was Jeffrey W Sherman's most active year for disposing of shares, totalling 32 transactions. Jeffrey W Sherman's most active month to dispose stocks was the month of December. 2004 saw Jeffrey W Sherman paying a total of $598,706.00 for 30,100 shares, this is the most they've acquired in one year. In 2023 Jeffrey W Sherman cashed out on 690,293 shares for a total of $32,369,978.73, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Horizon Therapeutics Public Ltd Co No price found
EVP and Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -234.76K |
$116.50 | -$27,349,423.50 |
0
|
Oct 6
| |||
Form 4
| -2.61% | -2.17K |
—
|
—
| 80.94K |
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
| 85.48K |
Jan 17
| |||
Form 4
| -15.70% | -6.74K |
$113.07 | -$761,673.20 | 36.17K |
Scheduled
|
Jan 10 - Jan 11
| ||
Form 4
| +33.79% | 23.29K |
$113.27 | -$3,153,087.43 | 92.22K |
Scheduled
|
Jan 4 - Jan 6
| ||
Form 4
| +507.58% | 12.05K |
$113.80 | -$1,105,794.60 | 14.43K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
| -16.71% | -28.35K |
$111.45 | -$3,159,691.71 | 141.31K |
Scheduled
|
May 27 - Dec 12
| ||
Form 4
| -79.81% | -42.01K |
$110.02 | -$4,621,872.19 | 10.63K |
Scheduled
|
Apr 6
| ||
Form 4
| +8.79% | 8.53K |
$22.14 | $188,876.34 | 105.58K |
May 25 - Mar 18
| |||
Form 4
| +5.30% | 2.98K |
$86.42 | -$204,988.24 | 59.29K |
Jan 21
| |||
Form 4
| +100.48% | 47.15K |
—
|
—
| 94.07K |
Nov 8 - Jan 5
| |||
Form 4
| +117.71% | 10.73K |
$7.61 | $81,647.69 | 19.84K |
Oct 27
| |||
Form 4
|
—
|
0
|
$58.81 | -$4,737,687.69 | 36.19K |
Scheduled
|
Sep 3 - Sep 21
| ||
Form 4
| +44.34% | 4.04K |
$102.50 | -$329,537.50 | 13.16K |
Jul 28
| |||
Form 4
| -22.69% | -60.08K |
$95.00 | -$5,707,362.45 | 204.69K |
Scheduled
|
Mar 10 - Jul 1
| ||
Form 4
| +1.39% | 1.09K |
$87.17 | -$75,925.07 | 80.08K |
Feb 17
| |||
Form 4
| +1.15% | 2.98K |
$77.43 | -$183,663.96 | 262.62K |
Dec 29 - Jan 21
| |||
Form 4
| +202.29% | 56.67K |
$73.28 | -$3,316,359.68 | 84.69K |
Jan 4 - Jan 5
| |||
Form 4
| -37.25% | -103.84K |
$71.02 | -$7,375,214.11 | 174.96K |
Scheduled
|
Dec 7 - Dec 8
| ||
Form 4/A
| +86.58% | 13K |
$7.61 | $98,930.00 | 28.02K |
Oct 21
| |||
Form 4
| +86.58% | 13K |
$7.61 | $98,930.00 | 28.02K |
Oct 21
| |||
Form 4
| -3.16% | -9.10K |
$57.50 | -$523,250.00 | 278.8K |
Scheduled
|
Jul 6
| ||
Form 4
|
—
|
0
|
$24.98 | -$1,340,499.16 | 13.97K |
Scheduled
|
May 11
| ||
Form 4
| +60.92% | 5.29K |
$12.94 | $68,413.78 | 13.97K |
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +5.32% | 10.72K |
$13.86 | -$118,198.08 | 212.34K |
Mar 23
| |||
Form 4
| +4.04% | 7.82K |
$15.02 | -$115,353.60 | 201.62K |
Jan 2
| |||
Form 4
| +5.75% | 10.45K |
$14.56 | -$128,098.88 | 192.35K |
Mar 23
| |||
Form 4
| +8.43% | 14.15K |
$16.18 | -$203,900.36 | 181.9K |
Jan 2
| |||
Form 4
| +5.34% | 8.5K |
$2.40 | $20,400.00 | 167.75K |
Dec 16
| |||
Form 4
| -1.79% | -2.90K |
$20.00 | -$58,000.00 | 159.25K |
Scheduled
|
Aug 2
| ||
Form 4
| +6.98% | 10.45K |
$16.32 | -$143,583.36 | 160.1K |
Mar 23
| |||
Form 4
| -2.67% | -4.10K |
$20.00 | -$82,000.00 | 149.65K |
Scheduled
|
Feb 26
| ||
Form 4
| +13.41% | 18.17K |
$21.67 | -$185,841.92 | 153.75K |
Jan 2
| |||
Form 4
| +28.96% | 30.44K |
$3.89 | $118,352.32 | 135.57K |
Dec 15
| |||
Form 4
| +4.43% | 4.46K |
$20.00 | $89,120.00 | 105.13K |
Scheduled
|
Dec 10
| ||
Form 4/A
| +4.24% | 4.46K |
$20.40 | -$76,540.80 | 109.59K |
Dec 8
| |||
Form 4
| +4.24% | 4.46K |
$21.40 | -$80,292.80 | 109.59K |
Dec 8
| |||
Form 4
| -6.87% | -7.75K |
$31.78 | -$246,295.00 | 105.13K |
Scheduled
|
Sep 21
| ||
Form 4
|
—
|
0
|
$19.09 | -$885,032.05 | 112.88K |
Scheduled
|
Jul 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4/A
| +12.32% | 11.25K |
—
|
—
| 102.6K |
Jan 2
| |||
Form 4
| +7.05% | 5.55K |
$12.99 | -$34,501.44 | 84.34K |
Dec 8
| |||
Form 4
| +21.34% | 18K |
$12.80 | -$112,038.40 | 102.33K |
Jan 2
| |||
Form 4
| -25.18% | -25.00K |
$12.05 | -$301,237.95 | 74.3K |
Nov 19
| |||
Form 4
|
∞
| 99.3K |
—
|
—
| 99.3K |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -99.30K |
—
|
—
|
0
|
Sep 19
| |||
Form 4
| -9.12% | -9.36K |
$12.94 | -$121,131.34 | 93.23K |
Scheduled
|
May 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +40.31% | 26.25K |
—
|
—
| 91.35K |
Dec 5 - Dec 9
| |||
Form 4
| +42.03% | 16.3K |
$2.36 | $38,477.44 | 55.1K |
Scheduled
|
Jan 2
| ||
Form 4
| +12.99% | 8.21K |
—
|
—
| 71.4K |
Dec 10
| |||
Form 4
| +117.42% | 33K |
—
|
—
| 61.1K |
Jul 26
| |||
Form 4
|
∞
| 22K |
—
|
—
| 22K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
XERIS PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xeris Biopharma Holdings, Inc. (XERS) Snapshot price: $2.6696
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +43.71% | 50K |
—
|
—
| 164.38K |
Jun 5
| |||
Form 4
| +6.03% | 6.5K |
—
|
—
| 114.38K |
Mar 15
| |||
Form 4
|
∞
| 5.4K |
$1.87 | $10,098.00 | 5.4K |
Nov 27
| |||
Form 4
| +65.01% | 42.5K |
—
|
—
| 107.88K |
Jun 7
| |||
Form 4
| +29.77% | 15K |
—
|
—
| 65.38K |
Jun 8
| |||
Form 4
|
∞
| 50.38K |
—
|
—
| 50.38K |
Oct 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Strongbridge Biopharma plc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -64.26K |
—
|
—
|
0
|
Oct 5
| |||
Form 4
| -21.66% | -17.76K |
$2.06 | -$36,591.78 | 64.26K |
Oct 1
| |||
Form 4
| +95.19% | 40K |
—
|
—
| 82.02K |
May 18
| |||
Form 4
| -31.07% | -18.94K |
$2.35 | -$44,518.40 | 42.02K |
May 14
| |||
Form 4
| -23.79% | -19.04K |
$2.86 | -$54,440.10 | 60.97K |
May 15
| |||
Form 4
| +100.00% | 40K |
—
|
—
| 80K |
May 14
| |||
Form 4
|
∞
| 40K |
—
|
—
| 40K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Larimar Therapeutics, Inc. (LRMR) Snapshot price: $5.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||